| Date | Time | Source | Headline | Symbol | Company |
| 03/26/2015 | 10:12AM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 02/17/2015 | 12:10PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 02/20/2014 | 5:00PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 11/04/2013 | 2:23PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/30/2013 | 6:00AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 7:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 7:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 6:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 5:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 5:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 5:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 4:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 3:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 3:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 3:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/28/2013 | 2:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/25/2013 | 5:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:32PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:32PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:32PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:31PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:31PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:31PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:31PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:30PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 2:29PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 12:55PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/24/2013 | 9:47AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/23/2013 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 10/15/2013 | 9:23AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |